Empagliflozin-induced Diabetic Ketoacidosis Unmasking a Type 1 Diabetes Diagnosis

Empagliflozin is a sodium glucose cotransporter-2 inhibitor that inhibits renal glucose reabsorption through an insulin-independent mechanism. This class of drugs is used in the management of type 2 diabetes. A 49-year-old female with type 2 diabetes treated with empagliflozin presented to the emerg...

Descripción completa

Detalles Bibliográficos
Autores principales: Ray, Gretchen M., Rodriguez, Chelsea, Schulman, Samantha M., Sarangarm, Preeyaporn, Bardack, Michelle, Bouchonville, Matthew F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497210/
https://www.ncbi.nlm.nih.gov/pubmed/31061971
http://dx.doi.org/10.5811/cpcem.2019.2.41795
_version_ 1783415426569469952
author Ray, Gretchen M.
Rodriguez, Chelsea
Schulman, Samantha M.
Sarangarm, Preeyaporn
Bardack, Michelle
Bouchonville, Matthew F.
author_facet Ray, Gretchen M.
Rodriguez, Chelsea
Schulman, Samantha M.
Sarangarm, Preeyaporn
Bardack, Michelle
Bouchonville, Matthew F.
author_sort Ray, Gretchen M.
collection PubMed
description Empagliflozin is a sodium glucose cotransporter-2 inhibitor that inhibits renal glucose reabsorption through an insulin-independent mechanism. This class of drugs is used in the management of type 2 diabetes. A 49-year-old female with type 2 diabetes treated with empagliflozin presented to the emergency department in diabetic ketoacidosis (DKA). This case report details the series of events leading to the diagnosis of drug-induced DKA, which led to a change in the patient’s diagnosis from type 2 diabetes to type 1 diabetes.
format Online
Article
Text
id pubmed-6497210
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine
record_format MEDLINE/PubMed
spelling pubmed-64972102019-05-06 Empagliflozin-induced Diabetic Ketoacidosis Unmasking a Type 1 Diabetes Diagnosis Ray, Gretchen M. Rodriguez, Chelsea Schulman, Samantha M. Sarangarm, Preeyaporn Bardack, Michelle Bouchonville, Matthew F. Clin Pract Cases Emerg Med Case Report Empagliflozin is a sodium glucose cotransporter-2 inhibitor that inhibits renal glucose reabsorption through an insulin-independent mechanism. This class of drugs is used in the management of type 2 diabetes. A 49-year-old female with type 2 diabetes treated with empagliflozin presented to the emergency department in diabetic ketoacidosis (DKA). This case report details the series of events leading to the diagnosis of drug-induced DKA, which led to a change in the patient’s diagnosis from type 2 diabetes to type 1 diabetes. University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine 2019-03-05 /pmc/articles/PMC6497210/ /pubmed/31061971 http://dx.doi.org/10.5811/cpcem.2019.2.41795 Text en Copyright: © 2019 Ray et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) License. See: http://creativecommons.org/licenses/by/4.0/
spellingShingle Case Report
Ray, Gretchen M.
Rodriguez, Chelsea
Schulman, Samantha M.
Sarangarm, Preeyaporn
Bardack, Michelle
Bouchonville, Matthew F.
Empagliflozin-induced Diabetic Ketoacidosis Unmasking a Type 1 Diabetes Diagnosis
title Empagliflozin-induced Diabetic Ketoacidosis Unmasking a Type 1 Diabetes Diagnosis
title_full Empagliflozin-induced Diabetic Ketoacidosis Unmasking a Type 1 Diabetes Diagnosis
title_fullStr Empagliflozin-induced Diabetic Ketoacidosis Unmasking a Type 1 Diabetes Diagnosis
title_full_unstemmed Empagliflozin-induced Diabetic Ketoacidosis Unmasking a Type 1 Diabetes Diagnosis
title_short Empagliflozin-induced Diabetic Ketoacidosis Unmasking a Type 1 Diabetes Diagnosis
title_sort empagliflozin-induced diabetic ketoacidosis unmasking a type 1 diabetes diagnosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497210/
https://www.ncbi.nlm.nih.gov/pubmed/31061971
http://dx.doi.org/10.5811/cpcem.2019.2.41795
work_keys_str_mv AT raygretchenm empagliflozininduceddiabeticketoacidosisunmaskingatype1diabetesdiagnosis
AT rodriguezchelsea empagliflozininduceddiabeticketoacidosisunmaskingatype1diabetesdiagnosis
AT schulmansamantham empagliflozininduceddiabeticketoacidosisunmaskingatype1diabetesdiagnosis
AT sarangarmpreeyaporn empagliflozininduceddiabeticketoacidosisunmaskingatype1diabetesdiagnosis
AT bardackmichelle empagliflozininduceddiabeticketoacidosisunmaskingatype1diabetesdiagnosis
AT bouchonvillematthewf empagliflozininduceddiabeticketoacidosisunmaskingatype1diabetesdiagnosis

Ejemplares similares